J B Chemicals & Pharmaceuticals receives USFDA approval for Loratadine Tablets

Image
Capital Market
Last Updated : Jan 08 2021 | 2:16 PM IST
J B Chemicals & Pharmaceuticals announced that US FDA has approved Company's Abbreviated New Drug Application (ANDA) for Loratadine Tablets USP 10 mg (for treatment of allergic rhinitis caused by pollen and upper respiratory tract allergy) for over-the-counter (OTC) use. This product is generic version of Clartin tablet in the same strength of Bayer Healthcare LLC.

The Company expects to commercialize this product in Q1 of FY 2021-22 and is expected to improve Company's US sales.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jan 08 2021 | 2:03 PM IST

Next Story